<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Cross Labeling Oncology Drugs in Combination Regimens; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Cross Labeling Oncology Drugs in Combination Regimens; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-11-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Cross Labeling Oncology Drugs in Combination Regimens." This guidance describes FDA's current recommendations on including relevant information in labeling for oncology drugs approved for use in combination regimens. This guidance finalizes the draft guidance of the same title issued on November 20, 2020.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-23866</p>
    <p><strong>Publication Date:</strong> 2022-11-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/11/03/2022-23866/cross-labeling-oncology-drugs-in-combination-regimens-guidance-for-industry-availability">https://www.federalregister.gov/documents/2022/11/03/2022-23866/cross-labeling-oncology-drugs-in-combination-regimens-guidance-for-industry-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-23866</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
